Opendata, web and dolomites

Sea4Pain SIGNED

Development of a novel analgesic for chronic pain from marine-derived compounds

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 Sea4Pain project word cloud

Explore the words cloud of the Sea4Pain project. It provides you a very rough idea of what is the project "Sea4Pain" about.

platform    chronic    extremely    mode    global    worth    demonstrated    pain    250    neurons    51    efficacy    world    acting    population    opioid    inflict    drugs    2022    series    moderate    constantly    huge    capital    applies    suffer    biotechnological    supporting    pharmaceutical    pathologies    compounds    discovery    analgesic    strategy    crowdfunding    patented    class    marine    2015    channel    market    team    toxicity    quality    habituation    cagr    treatments    health    derivate    innovative    drug    noxious       professionals    compound    lab    differentiated    give    action    addiction    alternative    received    suffering    525    co    13    alleviate    grants    brain    drive    sensing    portuguese    billion    raised    patients    venture    disruptive    benefits    life    channels    2013    roll    founded    sea4pain    adverse    ion    ease    fifth    sea4us    modulator    38    switch    breakthroughs    derivatives    first    limited    expand    kv    biomedicine    modulate    severe    shows    pharmaceuticals   

Project "Sea4Pain" data sheet

The following table provides information about the project.

Coordinator
SEA4US BIOTECNOLOGIA E RECURSOS MARINHOS LDA 

Organization address
address: RUA DO POENTE S/N
city: SAGRES
postcode: 8650 378
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Portugal [PT]
 Project website http://sea4us.pt/en/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-05-01   to  2018-09-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    SEA4US BIOTECNOLOGIA E RECURSOS MARINHOS LDA PT (SAGRES) coordinator 50˙000.00

Map

 Project objective

'The Sea4Pain project will expand and define the development strategy for Sea4Us’s “Drug Discovery and Development Platform” – a platform that applies novel biotechnological approaches to exploit marine derived compounds for the development of novel pharmaceuticals highly relevant for biomedicine. The first lab-based research results have clearly demonstrated the benefits of marine compounds in a series of pathologies, like chronic pain, and the huge potential of its derivate products in the health market. In particular, our innovative breakthroughs will lead to the development of a unique, high efficacy analgesic (ion channel modulator), with reduced toxicity and limited side-effects (Sea4Pain). This extremely innovative approach shows a differentiated mode-of-action (acting directly in the 'pain switch'), that will give rise to a new class of pharmaceutical drugs with no expected adverse effects on the brain (currently being patented). The disruptive compound will modulate specific ion channels in pain-sensing neurons (Kv), for which there is no known modulator, and ease the suffering of one fifth of the World's population who constantly suffer from chronic pain. Sea4Pain will offer alternative treatments for patients suffering from moderate to severe chronic pain. Current drugs in the market (opioid derivatives and others) do alleviate pain but co-inflict important noxious effects (habituation, addiction, loss of drive) and great loss in quality of life. The global pain management drugs and devices market was estimated to be worth $38 billion in 2015 and reach $51 billion in 2022 at a CAGR of 4%. Founded in 2013, Sea4Us has received over 525.000€ in Portuguese and European Research Grants, raised 10.000€ with crowdfunding, and 250.000€ in venture capital, supporting a team of 13 professionals and is focused on developing the Sea4Pain roll-to-market of innovative treatments.'

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SEA4PAIN" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SEA4PAIN" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

TAPPXSSAI (2019)

Development of a system for automatic ad insertion into on-demand streaming video to provide new monetization mechanisms to the media industry

Read More  

VINOQUANT11SUPERPLUS (2019)

A digital based system for measuring, showing and regulation of the complexe system of wine feremtation with high precision via a Bluetooth -Refractometer, a Software and a Bluetooth Thermostat

Read More  

RoboSynFarm (2019)

Robotic Synthesis Farm

Read More